{"count": 3, "results": [{"_id": "37047198", "pmid": 37047198, "pmcid": "PMC10093862", "title": "Antidiabetic Drugs Can Reduce the Harmful Impact of Chronic Smoking on Post-Traumatic Brain Injuries", "journal": "Int J Mol Sci", "authors": ["Sivandzade F", "Alqahtani F", "Dhaibar H", "Cruz-Topete D", "Cucullo L"], "date": "2023-03-25T00:00:00Z", "doi": "10.3390/ijms24076219", "meta_date_publication": "2023 Mar 25", "meta_volume": "24", "meta_issue": "7", "meta_pages": "", "score": 50267.47, "text_hl": "In conclusion, our findings suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MF@@@ and @CHEMICAL_Rosiglitazone @CHEMICAL_MESH:D000077154 @@@RSG@@@ could reduce the harmful impact of chronic smoking on @<m>DISEASE_Epilepsy_Post_Traumatic</m> @DISEASE_MESH:D004834 @@@post-traumatic brain injuries@@@.", "citations": {"NLM": "Sivandzade F, Alqahtani F, Dhaibar H, Cruz-Topete D, Cucullo L. Antidiabetic Drugs Can Reduce the Harmful Impact of Chronic Smoking on Post-Traumatic Brain Injuries Int J Mol Sci. 2023 Mar 25;24(7):. PMID: 37047198", "BibTeX": "@article{37047198, title={Antidiabetic Drugs Can Reduce the Harmful Impact of Chronic Smoking on Post-Traumatic Brain Injuries}, author={Sivandzade F and Alqahtani F and Dhaibar H and Cruz-Topete D and Cucullo L}, journal={Int J Mol Sci}, volume={24}, number={7}}"}}, {"_id": "34023358", "pmid": 34023358, "title": "Metformin reduces neuroinflammation and improves cognitive functions after traumatic brain injury.", "journal": "Neurosci Res", "authors": ["DiBona VL", "Shah MK", "Krause KJ", "Zhu W", "Voglewede MM", "Smith DM", "Crockett DP", "Zhang H"], "date": "2021-11-01T00:00:00Z", "doi": "10.1016/j.neures.2021.05.007", "meta_date_publication": "2021 Nov", "meta_volume": "172", "meta_issue": "", "meta_pages": "99-109", "score": 50258.734, "text_hl": "Here, we show the @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ drug, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, significantly improves cognitive functions after controlled @<m>DISEASE_Epilepsy_Post_Traumatic</m> @DISEASE_MESH:D004834 @@@cortical impact@@@ (@<m>DISEASE_Epilepsy_Post_Traumatic</m> @DISEASE_MESH:D004834 @@@CCI) injury@@@ in @SPECIES_10090 @@@mice@@@, showing improved spatial learning and nest building. ", "citations": {"NLM": "DiBona VL, Shah MK, Krause KJ, Zhu W, Voglewede MM, Smith DM, Crockett DP, Zhang H. Metformin reduces neuroinflammation and improves cognitive functions after traumatic brain injury. Neurosci Res. 2021 Nov;172():99-109. PMID: 34023358", "BibTeX": "@article{34023358, title={Metformin reduces neuroinflammation and improves cognitive functions after traumatic brain injury.}, author={DiBona VL and Shah MK and Krause KJ and Zhu W and Voglewede MM and Smith DM and Crockett DP and Zhang H}, journal={Neurosci Res}, volume={172}, pages={99-109}}"}}, {"_id": "39867299", "pmid": 39867299, "title": "The PIKASO trial (Preventing Injured Knees from Osteoarthritis: Severity Outcomes): Rationale and design features for a randomized controlled trial.", "journal": "Osteoarthr Cartil Open", "authors": ["Jacobs CA", "Jones MH", "Collins JE", "Waddell LM", "Li X", "Winalski CS", "Pietrosimone B", "Kraus VB", "Otero M", "Wellsandt E", "Schmitt LC", "Spindler KP", "Anderson DD", "Rodeo SA", "Magnussen RA", "Wolf BR", "Hart JM", "Stone AV", "Conley CE", "Golightly YM", "Myer GD", "Snyder-Mackler L", "Lotz MK", "Kim JS", "McLeod MM", "Huebner JL", "Lisee C", "Selzer F", "Katz JN", "Long K", "Frier KC", "Betensky DJ", "Felson DT", "Losina E", "for PIKASO Team"], "date": "2024-12-23T00:00:00Z", "doi": "10.1016/j.ocarto.2024.100563", "meta_date_publication": "2025 Mar", "meta_volume": "7", "meta_issue": "1", "meta_pages": "100563", "score": 50251.266, "text_hl": "Objective: Given the high burden and increasing prevalence of @<m>DISEASE_Epilepsy_Post_Traumatic</m> @DISEASE_MESH:D004834 @@@post-traumatic osteoarthritis@@@ (@<m>DISEASE_Epilepsy_Post_Traumatic</m> @DISEASE_MESH:D004834 @@@PTOA@@@), identifying clinically beneficial strategies to prevent or delay its onset could improve the quality of life of those at high risk of developing the disease. ", "citations": {"NLM": "Jacobs CA, Jones MH, Collins JE, Waddell LM, Li X, Winalski CS, Pietrosimone B, Kraus VB, Otero M, Wellsandt E, Schmitt LC, Spindler KP, Anderson DD, Rodeo SA, Magnussen RA, Wolf BR, Hart JM, Stone AV, Conley CE, Golightly YM, Myer GD, Snyder-Mackler L, Lotz MK, Kim JS, McLeod MM, Huebner JL, Lisee C, Selzer F, Katz JN, Long K, Frier KC, Betensky DJ, Felson DT, Losina E, for PIKASO Team. The PIKASO trial (Preventing Injured Knees from Osteoarthritis: Severity Outcomes): Rationale and design features for a randomized controlled trial. Osteoarthr Cartil Open. 2025 Mar;7(1):100563. PMID: 39867299", "BibTeX": "@article{39867299, title={The PIKASO trial (Preventing Injured Knees from Osteoarthritis: Severity Outcomes): Rationale and design features for a randomized controlled trial.}, author={Jacobs CA and Jones MH and Collins JE and Waddell LM and Li X and Winalski CS and Pietrosimone B and Kraus VB and Otero M and Wellsandt E and Schmitt LC and Spindler KP and Anderson DD and Rodeo SA and Magnussen RA and Wolf BR and Hart JM and Stone AV and Conley CE and Golightly YM and Myer GD and Snyder-Mackler L and Lotz MK and Kim JS and McLeod MM and Huebner JL and Lisee C and Selzer F and Katz JN and Long K and Frier KC and Betensky DJ and Felson DT and Losina E and for PIKASO Team}, journal={Osteoarthr Cartil Open}, volume={7}, number={1}, pages={100563}}"}}]}